BNT142

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT142, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors [Phase 1, Phase 2]